Today's Video Headlines: 05/31/25
As a sales rep for drug manufacturers Questcor, Lisa Pratta always suspected the company’s business practices weren’t just immoral but illegal, too, as she explains in “False Claims — One Insider’s Impossible Battle Against Big Pharma Corruption” .
Lisa Pratta at her home In New Jersey. In 2011, Pratta began to spy on her employer Questcor, which she believed was overcharging patients by thousands of dollars for their medication Acthar.At a patient event in Freehold, NJ, in August 2011, a young woman walking with a cane asked Pratta if the drug she sold, Acthar, could help with her multiple sclerosis. When the woman mentioned she was a mother to two babies and also had been diagnosed with lymphoma, Pratta broke down.Senior citizens are happiest living in these US states, study says Mom sparks fierce debate after allowing her kids to skip final week of school: 'I don’t see the point' Pratta began working for Questcor in 2010 as the sales rep in the Northeast region for Acthar, a drug which helped relieve autoimmune and inflammatory disorders. “If prescribed correctly, Acthar could help people walk again. And talk again,” writes Pratta. From paying doctors to prescribe it to using bogus research studies proclaiming its miraculous efficacy, they were so successful that Achtar’s price rose from $40 per vial in 2000 to nearly $39,000 in 2019 — an increase of 97,000%. Pratta’s determination to do the right thing was partly the result of a traumatic childhood tainted by physical and sexual abuse.ActharThat tenacity was put to the test when Pratta began to uncover the extent of Questcor’s corruption. Some sales reps were making up to $4 million a year and, in turn, kept the physicians doing their bidding in a life of luxury. “The greed had just taken over. They took them on scuba diving trips and bought clothes and shoes for their wives. One guy bought his doctor a brand new Armani suit and expensed it to Questcor,” she recalls.Though she had deliberated about exposing Questcor, Pratta worried about the ramifications. “That’s all I could think about,” she says. “I was a single parent, mother of a special needs son and had a ton of debt from my divorce. The impetus to act came from former colleague, Pete Keller, who, also concerned about Questcor’s methods, had decided to tell the authorities. According to attorney Ross Begelman, Pratta served as a “relator,” feeding information from her company to the Federal government.Now he needed Pratta, who was still working there, to act as a “relator” and feed information to lawyers, including health care fraud attorneys Marc Orlow and Ross Begelman. To make the case, Pratta compiled as much evidence as possible, surreptitiously making notes at sales meetings and patient programs. “I used to write notes on the palm of my hand under the table,” she explains. “If I was at a cocktail party and somebody confessed what they were doing was bribery, I would write it on a napkin in the bathroom or even on my pants. Given the financial might of the industry she was battling, Pratta became acutely aware of her own safety. Before she turned whistleblower, Pratta researched other relators to see what happened to them. “Just to see if anybody was murdered,” she explains. “You know, a mysterious accident or a car blowing up.”“I would see cars sitting at the end of my block and I just got paranoid,” she says. “I was watching even more when I went in stores or the parking lot. I got a dashcam, too.” In January 2012, the Department of Justice began a preliminary investigation into Questcor. Soon, federal agents began calling at Pratta’s colleagues’ homes and she had to feign shock. But, she writes, “If I was the only one in the company who didn’t get an early-morning visit from the Feds, that wasn’t exactly helping me keep my cover.” Soon, Pratta’s clandestine role became second nature to her. “It didn’t feel like I was still working for the government. It was like being married to my ex — they were never around, and there was no communication,” she writes. After Questcor was acquired by Irish pharma-giant Mallinckrodt in 2014, pressure to deliver even higher sales increased exponentially and with it came even greater disregard for ethics. After Questcor was acquired by Irish pharma-giant Mallinckrodt in 2014, pressure to deliver even higher sales increased exponentially and with it came even greater disregard for ethics. In 2017, after she was repeatedly bullied by her boss, Pratta went to HR to complain but was fired soon after, although they maintained it was a corporate restructure, just to avoid a wrongful termination case. “Ironically, I wasn’t fired because I was a double agent feeding information to the Department of Justice. Instead, they got rid of me for the offense of daring to speak out about an abusive manager,” she writes. In March 2019, the Department of Justice served a 100-page lawsuit against Mallinckrodt, alleging illegal marketing of Acthar, bribing doctors to boost sales and defrauding government health care programs It also mentioned Pratta’s role in the case, meaning her long-held anonymity was now public knowledge. “I didn’t mind that my former bosses knew; I just wished I could have seen their faces when they put it all together. I hoped they felt that their lives were suddenly out of their control. In the wake of the lawsuit, Mallinckrodt filed for bankruptcy, a move which immediately halted all legal action against them, much to Pratta’s frustration. Worse still, a member of the New Jersey plumbers’ union with MS had his union file a class action lawsuit against Mallinckrodt — and, as Pratta’s identity was now revealed, and she was a New Jersey resident, he named her in it. “The plumbers’ union was not messing around,” she writes. “They were pissed, and rightly so. In 2018, they’d paid $26,100.28 forWhile that lawsuit against Pratta was ultimately thrown out, “by the time it was finally dismissed, I was left with almost $42,000 in attorneys’ fees,” she says. Nor did Pratta receive anywhere near the amount of compensation she could have been entitled to as a whistleblower. When Mallinckrodt settled out of court in March 2022, agreeing to pay just $26.3 million for violating the False Claims Act — far less than the amount had the case reached trial — it meant Pratta’s percentage share was even smaller. Worse still, it would now be paid in installments, once a year for the next eight years. “In reality, if I averaged it all out, it was as if I’d just stayed employed for another ten years instead of losing my job,” she reflects.Pratta at her home in Jew Jersey with many of the documents and files that supported her cause against Questcor.For Pratta, though, the long, expensive journey to justice had been worth all the anxiety and sleepless nights.Vividseats: Official Ticketing Partner of New York PostDem Rep. Jerrold Nadler's aide detained by DHS agents in NYC office after staff accused of 'harboring rioters'Pet hair beware: The all-new BISSELL FurFinder vacuum *really* sucksWhat to know about the SoHo crypto kidnapping case and the suspects John Woeltz, William Duplessie Lisa Pratta at her home In New Jersey. In 2011, Pratta began to spy on her employer Questcor, which she believed was overcharging patients by thousands of dollars for their medication Acthar.After Questcor was acquired by Irish pharma-giant Mallinckrodt in 2014, pressure to deliver even higher sales increased exponentially and with it came even greater disregard for ethics.Pratta at her home in Jew Jersey with many of the documents and files that supported her cause against Questcor.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Best NBA Player Props Today for May 11: Bank on Big Men in Big GamesFind out why our NBA player props for Sunday are keying on Pacers big Myles Turner and Thunder center Chet Holmgren. Plus, Donovan Mitchell keeps taking and making his shots on May 11, 2025.
Read more »
President Trump takes on 'Big Pharma' by signing executive order to lower drug pricesPresident Donald Trump signed an executive order the White House says is aimed at 'lowering drug prices and stopping foreign free-riding on American pharmaceutical innovation.'
Read more »
Cigna and CVS shares fall as Trump targets ‘middlemen’ in sweeping executive order against Big PharmaThe market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.
Read more »
How Big Pharma’s web of interests groups pushes its agenda across the countryPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »
Schweizer: From Qatar to QVAR, Trump Takes on Boeing and Big PharmaSource of breaking news and analysis, insightful commentary and original reporting, curated and written specifically for the new generation of independent and conservative thinkers.
Read more »
Big Pharma Front Groups Muddle Debate Over Drug Prices, Patient Advocates SayFearless Independent Journalism
Read more »